Wednesday, April 09, 2025 6:51:51 PM
Seve. I'll debate it with you if U like ...altho we need to throw in something about AMRN ...which has done well the last couple of days ...and also congratulate Ram for making his $ back on TSLA.
100 % plus tariff on products made in China ...if kept in place mean Co's like Best Buy will likely file for bankruptcy by year end .
Even Amazon has reportedly refused to allow containers filled with outdoor summer furniture ...to be loaded onto ships for transit to the US .
Why...because they know they can't add 100% onto their existing prices ...and sell the stuff ...and dont want to eat the cost of the tariff .
So despite the reprieve vs rest of world ...a 10% tariff that can be eaten by sellers and buyers ...the products made in China , can not .
So good news for AMRN is that the tariff applied to Chinese sourced API ( used by the generics ) is likely to be a lot higher than any tariff applied to non Chinese API .
So what do the generics do ...pretty much the only thing they can do is declare Force Menjure ...poster RMB will explain that if needed ...and hopefully that gets them out of their supply contracts .
Oh by the way re Russia ...last thing Putin wants is oil at $50 ...arent we there yet ? So if Trump can get oil under $50 it may force Putin to a deal ( although those in the Permian Basin won't be happy )
Kiwi
100 % plus tariff on products made in China ...if kept in place mean Co's like Best Buy will likely file for bankruptcy by year end .
Even Amazon has reportedly refused to allow containers filled with outdoor summer furniture ...to be loaded onto ships for transit to the US .
Why...because they know they can't add 100% onto their existing prices ...and sell the stuff ...and dont want to eat the cost of the tariff .
So despite the reprieve vs rest of world ...a 10% tariff that can be eaten by sellers and buyers ...the products made in China , can not .
So good news for AMRN is that the tariff applied to Chinese sourced API ( used by the generics ) is likely to be a lot higher than any tariff applied to non Chinese API .
So what do the generics do ...pretty much the only thing they can do is declare Force Menjure ...poster RMB will explain that if needed ...and hopefully that gets them out of their supply contracts .
Oh by the way re Russia ...last thing Putin wants is oil at $50 ...arent we there yet ? So if Trump can get oil under $50 it may force Putin to a deal ( although those in the Permian Basin won't be happy )
Kiwi
Recent AMRN News
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
